Date of Original Release: July 19, 2024
Date of Expiration: July 19, 2027
Estimated Time of Completion:  6 Hours

Target Audience
Dermatologists and others involved in the delivery of dermatologic care.

Statement of Need
The American Academy of Dermatology bases its CME activities on identified professional practice gaps, the educational needs which underlie these gaps, and emerging clinical research findings as these relate to dermatology. Learners should reflect upon clinical and scientific information presented in this CME activity and determine the need for further study.

Learning Objectives
Following participation in this activity, the learner should be able to:

• Identify new molecular testing tools to diagnosis skin cancer.
• Recognize the pros/cons of each molecular testing tool.
• Choose the appropriate molecular testing tool to diagnosis the patient.

Accreditation Statement
The American Academy of Dermatology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

AMA PRA Credit Statement
The American Academy of Dermatology designates this enduring material for a maximum of 6 AMA PRA Category 1 Credit^TM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

Instructions to Claim Credit
To Claim CME credit for this activity, the learner must complete the post-activity evaluation survey.

Planner & Reviewer

Dirk Elston, MD, FAAD
Professor and Chair of Dermatology
Medical University of South Carolina
Charleston, South Carolina

Faculty

Alina Bridges, DO, FAAD
Professor and Directory of Dermatopathology
Zucker School of Medicine
Northwell, New York

Aaron S. Farberg, MD, FAAD
Assistant Professor
Baylor Scott & White Health System
Dallas, Texas

Laura Ferris, MD, PhD, FAAD
Professor
University of Pittsburgh
Pittsburgh, Pennsylvania

Pedram Gerami, MD, FAAD
IDP Endowed Professor of Skin Cancer Research
Northwestern University
Chicago, IL

M. Yadira Hurley, MD, FAAD
Professor
St. Louis University
St. Louis, Missouri

Christine Jaworsky, MD, FAAD
Professor
Case Western Reserve University
Cleveland, Ohio

Rossitza Lazova, MD
Director of Dermatopathology
California Skin Institute
San Jose, California

Tricia Missall, MD, PhD, FAAD
Professor
University of Florida College of Medicine
Gainesville, Florida

Allen Strickler, MD, PhD, MPH, FAAD
Assistant Professor
Geisinger Medical Center
Danville, Pennsylvania

Staff

Christine Presta
Director, Digital Learning
Rosemont, Illinois

Janet Chester
Manager, Learning Resources
Rosemont, Illinois

Emma Hostetler
Coordinator, Learning Resources
Rosemont, Illinois

Dustin Herlich
Manager, Digital Learning
Rosemont, Illinois

Melinda Keske
Senior Coordinator, Digital Learning
Rosemont, Illinois

Camilia Schawel
Instructional Designer, Digital Learning
Rosemont, IL

Donna L. Roberts-Luttrell, CPT
Instructional Designer, Digital Learning
Rosemont, IL

Disclosures

All other planners, speakers, reviewers, and staff for this activity have no relevant financial relationships with ineligible companies (formerly known as commercial interests).

Conflict Mitigation Statement
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, the American Academy of Dermatology has implemented mechanisms, prior to the planning implementation of this activity, to identify and mitigate conflicts of interest for all individuals in a position to control the content.

Commercial Support
This activity is supported by an educational grant from Castle Biosciences.

Unapproved Use Disclosure
The American Academy of Dermatology requires CME faculty/authors to disclose to learners when products or procedures are being discussed are off-label (not approved for the indications being discussed), unlabeled (not approved for any indications), experimental and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. This information is intended solely for continuing medical education and is not intended to promote off-label use of these products/procedures. If you have questions, contact the medical affairs department of the manufacturer for the most recent approval information. Faculty/authors of this activity may be discussing information about pharmaceutical agents that is outside of the U.S. Food and Drug Administration approved labeling.

Disclaimer
The American Academy of Dermatology (AAD) is not responsible for statements made by the author(s). Statement or opinions expressed in this activity reflect the views of the author(s) and do not reflect the official policy of the AAD. The information provided in this CME activity is for continuing education purposes only, is not intended to establish a standard of care, and is not meant to substitute for independent medical judgment of a health provider relative to the diagnostic, management and treatment options of a specific patient’s medical condition. 

No Medical Advice
The information in this publication by the American Academy of Dermatology or any third party should not be considered medical advice and is not intended to replace consultation with a qualified dermatology professional. The American Academy of Dermatology does not answer specific medical questions or refer people to a particular dermatology professional.

Contact Information
For the American Academy of Dermatology Member Resource Center, please call (866) 503-7546.